医疗机构视角解读新《药品管理法》中使用假劣药的责任
The responsibility of using counterfeit and inferior drugs in the new drug administration law from the perspective of medical institutions
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |